In this study, we found that the protective mechanism of ibrutinib against viral- and bacterial-induced ALI involves the regulation of the BTK-, FLT3-, and EGFR-related signaling pathways and the suppression of inflammatory factors. The gene discussed is EGFR; the disease is acute respiratory distress syndrome.